Voloridge Investment Management
TRAW icon

Voloridge Investment Management’s Traws Pharma TRAW Stock Holding History

Voloridge Investment Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-810
Closed -$140K – 1905
2021
Q2 		$140K Buy
810
+713
+735% +$161K ﹤0.01% 1576
2021
Q1 		$36K Buy
+97
New +$36.6K ﹤0.01% 1348

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management's TRAW Position: Q3 2021 in Review

Voloridge Investment Management sold out of Traws Pharma (TRAW) in Q3 2021, closing a stake of 810 shares — an estimated $140K sold.

Voloridge Investment Management first reported a position in TRAW in Q1 2021 and held it in 2 quarters. The position peaked at $140K in Q2 2021. 34 funds tracked by Wall St. Rank hold TRAW as of Q3 2021.

  • Voloridge Investment Management reported no remaining Traws Pharma position as of Q3 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 810 Traws Pharma shares in Q3 2021, an estimated $140K.
  • Voloridge Investment Management first reported a position in Traws Pharma in Q1 2021 and held it in 2 quarters.
  • Voloridge Investment Management's Traws Pharma position peaked at $140K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2021.

Based on Voloridge Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.